Active — Not RecruitingNot Applicable

Suprascapular Nerve PRF for Central Sensitization and Neuropathic Pain

Turkey (Türkiye)60 participantsStarted 2025-02-27

Plain-language summary

Chronic shoulder pain affects quality of life and is often associated with central sensitization, leading to treatment resistance. Pulsed radiofrequency (PRF) of the suprascapular nerve, which innervates 70% of the shoulder joint, is a promising therapy for nociceptive and neuropathic pain. This study evaluates the effects of PRF on central sensitization and neuropathic pain in chronic shoulder pain. Clinical assessments will be conducted at baseline, 1 month, and 3 months post-treatment to determine PRF's potential in reducing central sensitization and improving shoulder function.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Chronic shoulder pain persisting for at least 3 months * Radiologically confirmed shoulder lesions, including: Rotator cuff tendinopathy Adhesive capsulitis Bursitis Osteoarthritis * At least two positive provocation tests (Neer, Hawkins, Jobe tests) * Shoulder pain resistant to conservative treatments, including: Nonsteroidal anti-inflammatory drugs (NSAIDs) Physical therapy Corticosteroid injections Exclusion Criteria: * Traumatic shoulder pain (e.g., fractures, dislocations) * History of shoulder surgery * Active inflammation or rheumatic diseases affecting the shoulder, including: Rheumatoid arthritis Polymyalgia rheumatica Ankylosing spondylitis * Cervical radiculopathy * Central nervous system diseases, such as: Multiple sclerosis Stroke Spinal cord injury

What they're measuring

Central Sensitization Inventory (CSI)

Timeframe: baseline, 1st and 3rd months

Trial details

NCT IDNCT06857409

SponsorGülçin Babaoğlu

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-10-01